102 related articles for article (PubMed ID: 1340121)
1. Synthesis and anti-HIV activity of oligoribonucleotides and their phosphorothioate analogs.
Agrawal S; Tang JY; Sun D; Sarin PS; Zamecnik PC
Ann N Y Acad Sci; 1992 Oct; 660():2-10. PubMed ID: 1340121
[No Abstract] [Full Text] [Related]
2. Effects of phosphorothioate oligodeoxyribonucleotide and oligoribonucleotides on human complement and coagulation.
Kandimalla ER; Shaw DR; Agrawal S
Bioorg Med Chem Lett; 1998 Aug; 8(16):2103-8. PubMed ID: 9873494
[TBL] [Abstract][Full Text] [Related]
3. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
[TBL] [Abstract][Full Text] [Related]
4. 2'-O-methyl, 2'-O-ethyl oligoribonucleotides and phosphorothioate oligodeoxyribonucleotides as inhibitors of the in vitro U7 snRNP-dependent mRNA processing event.
Cotten M; Oberhauser B; Brunar H; Holzner A; Issakides G; Noe CR; Schaffner G; Wagner E; Birnstiel ML
Nucleic Acids Res; 1991 May; 19(10):2629-35. PubMed ID: 1710340
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model.
Inagawa T; Nakashima H; Karwowski B; Guga P; Stec WJ; Takeuchi H; Takaku H
FEBS Lett; 2002 Sep; 528(1-3):48-52. PubMed ID: 12297278
[TBL] [Abstract][Full Text] [Related]
6. Interaction of cationic alpha-helical peptide with phosphorothioate DNA hybrid.
Kubo T; Fujii M
Nucleic Acids Symp Ser; 1999; (42):167-8. PubMed ID: 10780432
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of RNA miniduplexes via a synthetic linker approach. 2. Generation of covalently closed, double-stranded cyclic HIV-1 TAR RNA analogs with high Tat-binding affinity.
X Ma MY; McCallum K; Climie SC; Kuperman R; Lin WC; Sumner-Smith M; Barnett RW
Nucleic Acids Res; 1993 Jun; 21(11):2585-9. PubMed ID: 8332456
[TBL] [Abstract][Full Text] [Related]
8. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
[TBL] [Abstract][Full Text] [Related]
9. Abasic oligodeoxyribonucleoside phosphorothioates: synthesis and evaluation as anti-HIV-1 agents.
Iyer RP; Uznanski B; Boal J; Storm C; Egan W; Matsukura M; Broder S; Zon G; Wilk A; Koziolkiewicz M
Nucleic Acids Res; 1990 May; 18(10):2855-9. PubMed ID: 2349087
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of phosphorothioate-methylphosphonate oligonucleotide co-polymers.
Zhou L; Morocho AM; Chen BC; Cohen JS
Nucleic Acids Res; 1994 Feb; 22(3):453-6. PubMed ID: 8127684
[TBL] [Abstract][Full Text] [Related]
11. 4'-Thio-oligo-beta-D-ribonucleotides: synthesis of beta-4'-thio-oligouridylates, nuclease resistance, base pairing properties, and interaction with HIV-1 reverse transcriptase.
Bellon L; Barascut JL; Maury G; Divita G; Goody R; Imbach JL
Nucleic Acids Res; 1993 Apr; 21(7):1587-93. PubMed ID: 7683133
[TBL] [Abstract][Full Text] [Related]
12. Antiviral amphipathic oligo- and polyribonucleotides: analogue development and biological studies.
Hyde RM; Broom AD; Buckheit RW
J Med Chem; 2003 May; 46(10):1878-85. PubMed ID: 12723951
[TBL] [Abstract][Full Text] [Related]
13. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
[TBL] [Abstract][Full Text] [Related]
14. The synthesis of alternating alpha,beta-oligodeoxyribonucleotides with alternating (3'-->3')- and (5'-->5')-internucleotic linkages as potential therapeutic agents.
Koga M; Geyer SJ; Regan JB; Beaucage SL
Nucleic Acids Symp Ser; 1993; (29):3-4. PubMed ID: 8247779
[TBL] [Abstract][Full Text] [Related]
15. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.
Matsukura M; Shinozuka K; Zon G; Mitsuya H; Reitz M; Cohen JS; Broder S
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7706-10. PubMed ID: 3499613
[TBL] [Abstract][Full Text] [Related]
16. Template. Phosphorothioate oligonucleotides duplexes as inhibitors of HIV-1 reverse transcriptase.
Maury G; el Alaoui A; Morvan F; Müller B; Imbach JL; Goody RS
Biochem Biophys Res Commun; 1992 Aug; 186(3):1249-56. PubMed ID: 1380799
[TBL] [Abstract][Full Text] [Related]
17. Investigation of antisense DNA having C-5 polyamine substituted 2'-deoxyuridine derivative.
Sakai H; Moriguchi T; Suzuki H; Matsukura M; Shinozuka K
Nucleic Acids Res Suppl; 2001; (1):127-8. PubMed ID: 12836297
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of 2'-amido-nucleosides in oligodeoxynucleotides and oligoribonucleotides as a model for 2'-linked conjugates.
Hendrix C; Devreese B; Rozenski J; van Aerschot A; De Bruyn A; Van Beeumen J; Herdewijn P
Nucleic Acids Res; 1995 Jan; 23(1):51-7. PubMed ID: 7870590
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-HIV activity of phosphorothioate antisense DNA containing C-5 polyamine substituted 2'-deoxyuridine and/or acridine residues.
Shinozuka K; Okamoto T; Matsukura M; Sawai H
Nucleic Acids Symp Ser; 1997; (37):215-6. PubMed ID: 9586076
[TBL] [Abstract][Full Text] [Related]
20. Stereocontrolled solid-phase synthesis of phosphorothioate oligoribonucleotides using 2'-O-(2-cyanoethoxymethyl)-nucleoside 3'-O-oxazaphospholidine monomers.
Nukaga Y; Yamada K; Ogata T; Oka N; Wada T
J Org Chem; 2012 Sep; 77(18):7913-22. PubMed ID: 22931131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
